A digital care management platform to monitor clinical and subclinical disease activity in multiple sclerosis

icometrix developed a digital care management platform aiming at standardising multiple sclerosis (MS) patient care and allowing more data-driven clinical decisions in the MS care pathway. The platform integrates icobrain ms, a CE marked and FDA cleared solution that quantifies clinically relevant brain MRI changes in persons with MS with icompanion ms, a medical health application comprising patient-reported information in the period of time between neurology visits.

icobrain processes brain MR images using 3D U-net convolutional neural networks to produce annotated images of brain lesions and various brain regions. The electronic icobrain ms report includes brain volumetric information, comparisons with relevant normative populations, and tracking of lesions and brain volume changes to support medical interpretation. The icompanion patient app and HCP web portal contain symptom-logging and patient-reported tests for body function, cognitive function, and fatigue. Integration with icobrain ms reports is also supported.

icobrain’s input/output complies to the DICOM standard. icobrain supports integrations with hospitals’ Picture Archiving and Communication System (PACS) and electronic medical record (EMR) systems. icompanion ms is available on Android and iOS. The icompanion web portal for HCPs is accessible via web browsers.

Radiologists and neurologists; private and public hospitals, medical research centers, pharmaceutical companies, persons with multiple sclerosis.

icobrain is available as a cloud-based AI software-as-a-service solution (https://icometrix.com/services). icompanion ms is available free-of-charge to patients (https://icompanion.ms/).